Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07214870 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

StatusActive, Not Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Novo Nordisk A/S to Novo Nordisk A/S Show 5 more changesShow less
    • Enrollment closed, study ongoing
    • Final enrollment: 29 participants (planned 60)
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 3 of 5 entries
    • Site details revised
  2. Study site revisedv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 7, 2025 to Oct 8, 2025
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Novo Nordisk
268 trials monitored
See 15 trials at risk
NASH / MASH
687 trials monitored
See 22 trials at risk
The purpose of this clinical study is to find out if NNC4005-0001 is well-tolerated and safe for people who have increased body weight and increased liver fat. Participants will receive either NNC4005-0001, which is the treatment being tested, or a placebo, which is a treatment that contains no active medicine. The study will last for about for about 7 to 8 months.
Trial Details
NCT Number NCT07214870
Lead Sponsor Novo Nordisk A/S
Conditions
(from sponsor)		 Fatty Liver Disease
Related terms Non-alcoholic Fatty Liver Disease
Enrollment 29 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov